Koers GlobeImmune Inc Nasdaq
Aandelen
US37957B1008
Biotechnologie & Medisch Onderzoek
Omzet 2014 | 5,97 mln. 5,49 mln. | Omzet 2015 | 6,46 mln. 5,94 mln. | Marktkapitalisatie | 22,26 mln. 20,48 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2014 | -16 mln. -14,72 mln. | Nettowinst (verlies) 2015 | -2 mln. -1,84 mln. | EV/omzet 2014 | 4,5 x |
Nettoliquiditeiten 2014 | 16,81 mln. 15,47 mln. | Nettoliquiditeiten 2015 | 9,9 mln. 9,11 mln. | EV/omzet 2015 | 1,91 x |
K/w-verhouding 2014 |
-0,94
x | K/w-verhouding 2015 |
-8,04
x | Werknemers | - |
Dividendrendement 2014 * |
-
| Dividendrendement 2015 |
-
| Vrij verhandelbaar | 100% |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Augustine Lawlor
BRD | Director/Board Member | 67 | 01-06-03 |
Ehud Geller
BRD | Director/Board Member | 77 | - |
Charles C. Kim
BRD | Director/Board Member | - | - |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+9,58% | 115 mld. | |
+12,41% | 107 mld. | |
-3,23% | 21,6 mld. | |
-12,38% | 22,31 mld. | |
-6,36% | 19,19 mld. | |
-3,35% | 18,23 mld. | |
-38,57% | 17,62 mld. | |
+7,51% | 14,26 mld. | |
+35,67% | 12,37 mld. |